NCT07578558Phase 2Not yet recruiting

NAI for Sepsis With Persistent Lymphopenia

Study sponsor: ImmunityBio, Inc. · IBRX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-08-03Estimated
Enrollment · participants50Estimated
Source updated2026-05-11Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.